UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10117), p.230-240

2018

Volltextzugriff (PDF)

Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

The American journal of medicine, 2013, Vol.126 (1), p.13-20

2013

Volltextzugriff (PDF)

Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review

Advances in therapy, 2022-01, Vol.39 (1), p.58-74

2022

Volltextzugriff (PDF)

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

Journal of bone and mineral research, 2018-05, Vol.33 (5), p.783-794

2018

Volltextzugriff (PDF)

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

Journal of bone and mineral research, 2010-01, Vol.25 (1), p.72-81

2010

Volltextzugriff (PDF)

Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial

Bone (New York, N.Y.), 2020-01, Vol.130, p.115113, Article 115113

2020

Volltextzugriff (PDF)

Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis

Bone (New York, N.Y.), 2019-03, Vol.120, p.1-8

2019

Volltextzugriff (PDF)

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Journal of bone and mineral research, 2010-10, Vol.25 (10), p.2256-2265

2010

Volltextzugriff (PDF)

Romosozumab and antiresorptive treatment: the importance of treatment sequence

Osteoporosis international, 2022-06, Vol.33 (6), p.1243-1256

2022

Volltextzugriff (PDF)

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

Bone, 2008-12, Vol.43 (6), p.1115-1121

2008

Volltextzugriff (PDF)

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Journal of clinical densitometry, 2017, Vol.20 (1), p.8-24

2017

Volltextzugriff (PDF)

Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women

The journal of clinical endocrinology and metabolism, 2008-06, Vol.93 (6), p.2149-2157

2008

Volltextzugriff (PDF)

Loading dose vitamin D3 improves vitamin D insufficiency in adults undergoing hematopoietic stem cell transplantation: A randomized controlled trial

PloS one, 2023-10, Vol.18 (10), p.e0284644-e0284644

2023

Volltextzugriff (PDF)

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

The journal of clinical endocrinology and metabolism, 2011-04, Vol.96 (4), p.972-980

2011

Volltextzugriff (PDF)

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Endocrine reviews, 2005-08, Vol.26 (5), p.688-703

2005

Volltextzugriff (PDF)

Letter to the Editor: “Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use”

The journal of clinical endocrinology and metabolism, 2020-03, Vol.105 (3), p.e903-e904

2020

Volltextzugriff (PDF)

Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis

The American journal of medicine, 2019-11, Vol.132 (11), p.e771-e777

2019

Volltextzugriff (PDF)

Remodeling‐ and Modeling‐Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study

Journal of bone and mineral research, 2018-02, Vol.33 (2), p.298-306

2018

Volltextzugriff (PDF)

High-Resolution Peripheral Quantitative Computed Tomography for the Assessment of Bone Strength and Structure: A Review by the Canadian Bone Strength Working Group

Current osteoporosis reports, 2013-06, Vol.11 (2), p.136-146

2013

Volltextzugriff (PDF)

Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Position Development Conference

Journal of clinical densitometry, 2008, Vol.11 (1), p.75-91

2008

Volltextzugriff (PDF)

Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed

Bone (New York, N.Y.), 2020-05, Vol.134, p.115287-115287, Article 115287

2020

Volltextzugriff (PDF)

Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2‐Yr Results of a Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Study

Journal of bone and mineral research, 2008-04, Vol.23 (4), p.525-535

2008

Volltextzugriff (PDF)

Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review

Endocrinology and metabolism (Seoul), 2023-02, Vol.38 (1), p.56-68

2023

Volltextzugriff (PDF)

Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology

Bone (New York, N.Y.), 2015-12, Vol.81, p.122-130

2015

Volltextzugriff (PDF)

1 – 25 von 303

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(258)

Publikationsform

Artikel
(301)
Texte
(1)
Webseiten
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(208)
Humans
(203)
Female
(130)
Osteoporosis
(94)
Endocrinology & Metabolism
(91)
Aged
(77)
Male
(77)
Middle Aged
(74)
Biological And Medical Sciences
(71)
Medical Sciences
(64)
Bone Density
(58)
Risk Factors
(52)
Psychiatry
(44)
Adult
(43)
Aged, 80 And Over
(35)
Bone Density Conservation Agents - Therapeutic Use
(35)
Fractures
(35)
Schizophrenia
(34)
Schizophrenia - Genetics
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial

Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Romosozumab and antiresorptive treatment: the importance of treatment sequence

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ

Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women

Loading dose vitamin D3 improves vitamin D insufficiency in adults undergoing hematopoietic stem cell transplantation: A randomized controlled trial

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Letter to the Editor: “Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use”

Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis

Remodeling‐ and Modeling‐Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study

High-Resolution Peripheral Quantitative Computed Tomography for the Assessment of Bone Strength and Structure: A Review by the Canadian Bone Strength Working Group

Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Position Development Conference

Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed

Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2‐Yr Results of a Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Study

Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review

Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology

Suchergebnisse filtern